PubMed for Bookshelf ID: 4719442

Year	Number of Results
1988	1
1997	1
2004	2
2007	1
2008	1
2009	1
2010	1
2013	2
2014	1
2016	1
2017	2
2018	2
2024	0

1

Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.

Bisaga A, Mannelli P, Sullivan MA, Vosburg SK, Compton P, Woody GE, Kosten TR. Bisaga A, et al. Am J Addict. 2018 Apr;27(3):177-187. doi: 10.1111/ajad.12711. Am J Addict. 2018. PMID: 29596725 Free PMC article. Review.

2

Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.

Karkhanis A, Holleran KM, Jones SR. Karkhanis A, et al. Int Rev Neurobiol. 2017;136:53-88. doi: 10.1016/bs.irn.2017.08.001. Epub 2017 Sep 12. Int Rev Neurobiol. 2017. PMID: 29056156 Review.

3

Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.

Sridharan K, Sivaramakrishnan G. Sridharan K, et al. J Pain Symptom Manage. 2018 Feb;55(2):468-479.e1. doi: 10.1016/j.jpainsymman.2017.08.022. Epub 2017 Sep 15. J Pain Symptom Manage. 2018. PMID: 28919541 Free article.

4

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Dowell D, Haegerich TM, Chou R. Dowell D, et al. JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464. JAMA. 2016. PMID: 26977696 Free PMC article. Review.

5

Withdrawal syndrome caused by naltrexone in opioid abusers.

Hassanian-Moghaddam H, Afzali S, Pooya A. Hassanian-Moghaddam H, et al. Hum Exp Toxicol. 2014 Jun;33(6):561-7. doi: 10.1177/0960327112450901. Epub 2013 May 20. Hum Exp Toxicol. 2014. PMID: 23690227

6

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.

Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Walley AY, et al. BMJ. 2013 Jan 30;346:f174. doi: 10.1136/bmj.f174. BMJ. 2013. PMID: 23372174 Free PMC article.

7

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers.

Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD. Comer SD, et al. Addiction. 2010 Apr;105(4):709-18. doi: 10.1111/j.1360-0443.2009.02843.x. Addiction. 2010. PMID: 20403021 Free PMC article. Clinical Trial.

8

Peripheral mechanisms of opioid analgesia.

Stein C, Lang LJ. Stein C, et al. Curr Opin Pharmacol. 2009 Feb;9(1):3-8. doi: 10.1016/j.coph.2008.12.009. Epub 2009 Jan 20. Curr Opin Pharmacol. 2009. PMID: 19157985 Review.

9

Methylnaltrexone for opioid-induced constipation in advanced illness.

Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ. Thomas J, et al. N Engl J Med. 2008 May 29;358(22):2332-43. doi: 10.1056/NEJMoa0707377. N Engl J Med. 2008. PMID: 18509120 Free article. Clinical Trial.

10

Naltrexone long-acting formulation in the treatment of alcohol dependence.

Johnson BA. Johnson BA. Ther Clin Risk Manag. 2007 Oct;3(5):741-9. Ther Clin Risk Manag. 2007. PMID: 18472999 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year